Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ampio Pharmaceuticals (NY: AMPE )

0.1587 -0.0128 (-7.46%)
Streaming Delayed Price Updated: 2:16 PM EDT, May 25, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,137,980
Open 0.1715
Bid (Size) 0.1587 (1)
Ask (Size) 0.1611 (4)
Prev. Close 0.1715
Today's Range 0.1581 - 0.1732
52wk Range 0.1619 - 1.990
Shares Outstanding 227,186,867
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Ampio's Independent Committee Launches Investigation Related To AP-013 Trial
 
Via Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga

Performance

YTD
-74.24%
-74.24%
1 Month
-45.09%
-45.09%
3 Month
-63.93%
-63.93%
6 Month
-85.70%
-85.70%
1 Year
-91.69%
-91.69%

More News

Read More
Ampio Pharmaceuticals: Q1 Earnings Insights
Via Benzinga
22 Stocks Moving in Friday's Pre-Market Session
Via Benzinga
74 Biggest Movers From Yesterday
Via Benzinga
Mid-Afternoon Market Update: Nasdaq Down 200 Points; United Airlines Shares Jump
Via Benzinga
55 Biggest Movers From Friday
Via Benzinga
Mid-Day Market Update: Nasdaq Turns Negative; US Weekly Jobless Claims Edge Lower
Via Benzinga
60 Biggest Movers From Yesterday
Via Benzinga
30 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
The Daily Biotech Pulse: Ampio Falls On Knee Osteoarthritis Trial Update, AstraZeneca's COVID-19 Antibody Data, CureVac-GSK's Bivalent COVID-19 Vaccine Data
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Ampio Pharma Shares Fall As FDA Rejects Proposed Change In Knee Osteoarthritis Trial
Via Benzinga
26 Stocks Moving in Thursday's Pre-Market Session
Via Benzinga
The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia
Via Benzinga
Earnings Scheduled For March 29, 2022
Via Benzinga
Earnings Preview For Ampio Pharmaceuticals
Via Benzinga
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 24, 2022
Via Benzinga
63 Biggest Movers From Yesterday
Via Benzinga
Why Ampio Pharmaceuticals Stock Is Rising Today
Via Benzinga
The Daily Biotech Pulse: NuCana Shelves Biliary Tract Cancer Study, Tricida Data Readout Pushed Back Due to Ukrainian Crisis, Synlogic Names New CFO
Via Benzinga
26 Stocks Moving in Thursday's Pre-Market Session
Via Benzinga
Ampio Highlights Promising Ampion Data In Knee Osteoarthritis
Via Benzinga
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
Via Benzinga
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.